A compound very similar to the mycotoxin citrinin was observed on thin-layer chromatographic plates during the screening analysis of grain extracts. This compound was produced by 22 of the tested Fusarium avenaceum (Corda ex Fries) Sacc. strains isolated from wheat, triticale, barley, corn, and potatoes. A chemical test confirmed the presence of an unknown compound, which was given the preliminary name of antibiotic Y (indicating yellow fluorescence). The following properties of the new metabolite are described: spectroscopic (UV, infrared, proton nuclear magnetic resonance, fluorescence, and mass spectrometry), phytotoxic, antibiotic (inhibitory effect of bacterial growth), and toxic (toxicity to Artemia salina, chicken embryos, and mouse fibroblasts). Elemental analysis of the compound showed that it had the general formula C15H1008, in agreement with the mass spectrometric finding that the molecular ion had a molecular weight of 318. The structure of the compound is presently under study.
Fusarium avenaceum (Corda ex Fries) Sacc. has been recognized for many years as a pathogen of several plants (e.g., cereals, legumes, and potatoes), causing serious losses every year (3) . However, secondary metabolites of F. avenaceum are not as well known as are metabolites of F. graminearium or F. culmorum. Cook et al. (6) discovered the antibiotic avenacein in F. avenaceum cultures.
The fungus has been recognized in some papers as a zearalenone producer (12). Recently it was found to be a producer of moniliformin (4, 11) . A compound with properties similar to those of citrinin has been detected in cultures of F. avenaceum (5) . In this paper we report the biosynthesis, isolation, purification, and some properties of this compound.
MATERIALS AND METHODS
Fungal strains. F. avenaceum (Corda ex Fries) Sacc. strains were isolated from wheat, triticale, barley, corn, and potatoes. Taxonomy of the strains was performed by the method of Booth (3) .
Biosynthesis of antibiotic Y. F. avenaceum KF 58, isolated from wheat stems, was used to produce the compound by a 4-week incubation on 200-g portions of sterilized whole corn kernels in 1,000-ml Erlenmeyer flasks at 20°C and 40% water content.
(The biosynthesis, isolation, and purification of antibiotic Y are proprietory under Polish patent P251215, January
1985.)
Isolation of antibiotic Y. The compound was extracted from 1 kg of air-dried ground culture on corn kernels by using seven 1,000-ml portions of a mixture containing chlo-* Corresponding author. roform and 0.2 M phosphoric acid (5:1, vol/vol, pH 2). Combined chloroform extracts were evaporated to 500 ml.
Purification of antibiotic Y. (i) After isolation, antibiotic Y was extracted with seven 500-ml portions of a saturated solution of sodium bicarbonate. (ii) The combined aqueous layers were acidified with 20% HCl to pH 2 and then reextracted with four 300-ml portions of chloroform. (iii) Combined chloroform layers were evaporated to 500 ml, steps (i) and (ii) were repeated, and the final chloroform layer was dried over MgSO4, filtered, and then evaporated to dryness. About 1 The melting point (281 to 282°C) is fairly high and may indicate an acidic character due to free carboxylic group(s). The solubility of the compound decreased with every step of purification. The compound was relatively easily extracted from fungal culture with acidified chloroform, whereas pure recrystallized antibiotic Y was hardly soluble in such solvents as CHCl3, CHCl3/CH3COOH, CH30H/CH3COOH, acetone, dimethyl sulfoxide, ethanol, water, or saturated water solutions of Na2CO3 or NaHCO3. Addition of tetraethylammonium hydroxide to crystalline antibiotic Y significantly increased the solubility. Aqueous solutions for all biological tests were prepared in this way (see phytotoxicity tests in Materials and Methods).
The following properties were observed and measured. Antibiotic Y showed no phytotoxicity effect toward wheat and pea seedling growth up to a concentration of 100 ,g/ml. In comparison, vomitoxin at 5 Fg/ml inhibited the growth of seedlings.
Inhibitory effects of the compound on bacterial growth are presented in Tables 1 and 2 for the disk and serial dilution methods, respectively. The MIC of antibiotic Y depends very much on the pH and seems to be directly proportional to the acidic character of the compound. The inhibitory effect of the compound on bacterial growth increased more than 10-fold when the pH was lowered from 7.4 to 6.2. The MIC at pH 6.2 (0.37 ,ug/ml) indicates that the compound has very active antibiotic properties, even higher than those of streptomycin for S. aureus 209 P (MIC at pH 6.2, 18.8 p.g/ml).
The antibiotic properties of the compound toward phytopathogenic bacteria, particularly B. subtilis and E. carotovora, were also investigated. Agrobacterium tumefaciens was found to be only slightly sensitive to per 0.1 ml of larval suspension) depended on pH and was measured at 52.0, 54.0, and 70.0 ,ug/0.1 ml for pH 6.5, 7.1, 7.4, respectively. For a broad range of doses (0.5 to 200 ,ug of antibiotic Y per egg), the compound was found to be nontoxic in the chicken embryo bioassay. Antibiotic Y in concentrations up to 5,000 ng/ml was found to be nontoxic to 3T3 mouse cells.
Taking into consideration all the results of the biological activity of the compound, we conclude that antibiotic Y is a very interesting substance for several reasons. The very high and specific inhibitory effect on bacterial growth and the low or negligible toxicity allow the compound to be used in medical treatment. The structure of antibiotic Y and its biosynthesis pathways are currently under study.
